Literature DB >> 16546676

Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.

Ananya Ruangma1, Bing Bai, Jason S Lewis, Xiankai Sun, Michael J Welch, Richard Leahy, Richard Laforest.   

Abstract

BACKGROUND: One of the limiting factors in achieving the best spatial resolution in positron emission tomography (PET), especially in small-animal PET, is the positron range associated with the decay of nuclides, and usual PET image reconstruction algorithms do not provide a correction for the positron range. This work presents initial results obtained with the maximum a posteriori (MAP) algorithm, which has been developed to include an accurate model of the camera response, the Poisson distribution of coincidence data and the fundamental physics of positron decay including the positron range.
METHODS: Phantoms were imaged with three positron emitting isotopes of Cu ((60)Cu, (61)Cu and (64)Cu), and mice and rats were imaged with two radiopharmaceuticals labeled with these isotopes in a microPET-R4 camera. These isotopes decay by positron emission with very different end-point energies resulting in wildly different spatial resolutions. Spatial resolution improvement and image quality offered by the MAP algorithm were studied with the line source phantom and a miniature Derenzo phantom. In addition, three mice and three rats were sequentially injected over a 48-h period with Cu-pyruvaldehyde bis(N(4)-methylthiosemicarbazone) (for blood flow to organs) and Cu-1,4,7,10-tetraazacyclododecane-1,4,7-tri(methanephosphonic acid) (for bone imaging) labeled with the said three isotopes of Cu.
RESULTS: The line source experiment showed that comparable spatial resolution is possible with all three isotopes when using the positron range correction in MAP. The in vivo images obtained from (60)Cu and (61)Cu and reconstructed with 2D filtered back projection algorithms provided by the camera manufacturer show reduced clarity due to degraded spatial resolution arising from the extended positron ranges as compared with (64)Cu. MAP reconstructions exhibited a higher resolution with clearer organ delineation.
CONCLUSION: Inclusion of a positron range model in the MAP reconstruction algorithm may potentially result in significant resolution recovery for isotopes with larger positron ranges.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546676     DOI: 10.1016/j.nucmedbio.2005.11.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  11 in total

1.  Noise propagation in resolution modeled PET imaging and its impact on detectability.

Authors:  Arman Rahmim; Jing Tang
Journal:  Phys Med Biol       Date:  2013-09-13       Impact factor: 3.609

Review 2.  Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls.

Authors:  Arman Rahmim; Jinyi Qi; Vesna Sossi
Journal:  Med Phys       Date:  2013-06       Impact factor: 4.071

3.  A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  Dalton Trans       Date:  2011-03-25       Impact factor: 4.390

4.  Gold nanocages as photothermal transducers for cancer treatment.

Authors:  Jingyi Chen; Charles Glaus; Richard Laforest; Qiang Zhang; Miaoxian Yang; Michael Gidding; Michael J Welch; Younan Xia
Journal:  Small       Date:  2010-04-09       Impact factor: 13.281

5.  Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals.

Authors:  Ju-Chieh Kevin Cheng; Kooresh Shoghi; Richard Laforest
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

6.  Analytic system matrix resolution modeling in PET: an application to Rb-82 cardiac imaging.

Authors:  A Rahmim; J Tang; M A Lodge; S Lashkari; M R Ay; R Lautamäki; B M W Tsui; F M Bengel
Journal:  Phys Med Biol       Date:  2008-10-03       Impact factor: 3.609

Review 7.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

8.  Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.

Authors:  James R Bading; Magnus Hörling; Lawrence E Williams; David Colcher; Andrew Raubitschek; Sven E Strand
Journal:  Cancer Biother Radiopharm       Date:  2008-08       Impact factor: 3.099

Review 9.  The motivations and methodology for high-throughput PET imaging of small animals in cancer research.

Authors:  Nicolas Aide; Eric P Visser; Stéphanie Lheureux; Natacha Heutte; Istvan Szanda; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-13       Impact factor: 9.236

Review 10.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.